U.S. Supreme Court gives boost to whistleblowers in drug pricing case
By John Kruzel WASHINGTON (Reuters) – The U.S. Supreme Court on Thursday gave a boost to whistleblowers in their bid to revive lawsuits accusing pharmacy operators of knowingly overbilling government health insurance programs for prescription drugs at taxpayers’ expense. The justices in a 9-0 decision threw out a lower court’s ruling that said the pharmacies …
U.S. Supreme Court gives boost to whistleblowers in drug pricing case Read More »